{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:56:08Z","timestamp":1787003768616,"version":"build-2736575974"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum f\u00fcr Infektionsforschung","doi-asserted-by":"publisher","award":["TTU 03.913"],"award-info":[{"award-number":["TTU 03.913"]}],"id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum f\u00fcr Infektionsforschung","doi-asserted-by":"publisher","award":["TTU 03.905"],"award-info":[{"award-number":["TTU 03.905"]}],"id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"HHS | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006370","name":"Small Business Innovation Research","doi-asserted-by":"publisher","award":["5R44AI055229"],"award-info":[{"award-number":["5R44AI055229"]}],"id":[{"id":"10.13039\/100006370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006370","name":"Small Business Innovation Research","doi-asserted-by":"publisher","award":["2R44AI058375"],"award-info":[{"award-number":["2R44AI058375"]}],"id":[{"id":"10.13039\/100006370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB544"],"award-info":[{"award-number":["SFB544"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["BO 2494\/3-2"],"award-info":[{"award-number":["BO 2494\/3-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["BO 2494\/7-1"],"award-info":[{"award-number":["BO 2494\/7-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001655","name":"Deutscher Akademischer Austauschdienst","doi-asserted-by":"publisher","award":["57592740"],"award-info":[{"award-number":["57592740"]}],"id":[{"id":"10.13039\/501100001655","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001713","name":"EC | H2020 | ERA-LEARN | European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","award":["101145698"],"award-info":[{"award-number":["101145698"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Angewandte Klinische Forschung","award":["346-0-0"],"award-info":[{"award-number":["346-0-0"]}]},{"name":"Max Planck Institute for Infection Biology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"published-print":{"date-parts":[[2025,11,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    To develop a\n                    <jats:italic>Plasmodium falciparum<\/jats:italic>\n                    (Pf) vaccine that precludes replication inside the host for improved vaccine safety, we tested chemo-attenuation (CVac) of sporozoites (SPZ) with atovaquone\u2013proguanil (AP). In mice,\n                    <jats:italic>P. berghei<\/jats:italic>\n                    sporozoites administered with AP invaded hepatocytes, arrested early, and induced robust protection, which correlated with parasite-specific effector-memory CD8+ T cell responses. In a clinical trial of PfSPZ-CVac (AP), in which three doses of 5.12\u2009\u00d7\u200910\n                    <jats:sup>4<\/jats:sup>\n                    or 1.5\u2009\u00d7\u200910\n                    <jats:sup>5<\/jats:sup>\n                    PfSPZ were administered by direct venous inoculation combined with oral single-dose AP (1000\/400\u2009mg), blood stage infections were fully prevented during immunisation. 2\/8 and 2\/10 of vaccinees, respectively, were protected when challenged with 3.2\u2009\u00d7\u200910\n                    <jats:sup>3<\/jats:sup>\n                    PfSPZ 10 weeks later, inferior to PfSPZ-CVac (chloroquine\/CQ) that allows in-host replication. Comparative analysis of responses to 228 Pf proteins revealed that protection with PfSPZ-CVac (CQ) was associated with antibodies to two liver-stage antigens (LISP2, LSA1) and a multi-stage antigen (PfMSP5), but not to the major surface protein PfCSP. The complete arrest of high numbers of Pf sporozoites by single-dose AP should allow a significant dose-frequency reduction of the current daily AP malaria chemoprophylaxis regimen.\n                  <\/jats:p>","DOI":"10.1038\/s44321-025-00301-8","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T13:03:22Z","timestamp":1759151002000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Complete attenuation of Plasmodium falciparum sporozoites by atovaquone\u2013proguanil"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9189-4393","authenticated-orcid":false,"given":"Steffen","family":"Borrmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4311-4509","authenticated-orcid":false,"given":"Zita","family":"Sulyok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5100-0981","authenticated-orcid":false,"given":"Katja","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4716-0311","authenticated-orcid":false,"given":"Rolf","family":"Fendel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mih\u00e1ly","family":"Sulyok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Friesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4692-7835","authenticated-orcid":false,"given":"Albert","family":"Lalremruata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thaisa Lucas","family":"Sandri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5433-7712","authenticated-orcid":false,"given":"The Trong","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6766-1765","authenticated-orcid":false,"given":"Carlos Lamsfus","family":"Calle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Knoblich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Sefried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6215-6332","authenticated-orcid":false,"given":"Javier","family":"Ib\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7401-2720","authenticated-orcid":false,"given":"Freia-Raphaella","family":"Lorenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri Lynn","family":"Heimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M","family":"Weller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Steuder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3173-996X","authenticated-orcid":false,"given":"Selorme","family":"Adukpo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Granados Bayon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zs\u00f3fia","family":"Moln\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meral","family":"Esen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Metzger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric R","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Ruben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonas","family":"Abebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumana","family":"Chakravarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Manoj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"KC","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tooba","family":"Murshedkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5452-9263","authenticated-orcid":false,"given":"Julius C R","family":"Hafalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9508-1787","authenticated-orcid":false,"given":"Tamirat Gebru","family":"Woldearegai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"O\u2019Rourke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Held","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1142-4813","authenticated-orcid":false,"given":"Pete","family":"Billingsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8598-8905","authenticated-orcid":false,"given":"B Kim Lee","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2946-5456","authenticated-orcid":false,"given":"Thomas L","family":"Richie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen L","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G","family":"Kremsner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6147-8591","authenticated-orcid":false,"given":"Kai","family":"Matuschewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9101-2768","authenticated-orcid":false,"given":"Benjamin","family":"Mordm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"301_CR1","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4269\/ajtmh.15-0621","volume":"94","author":"GJ Bastiaens","year":"2016","unstructured":"Bastiaens GJ, van Meer MP, Scholzen A, Obiero JM, Vatanshenassan M, van Grinsven T, Sim BK, Billingsley PF, James ER, Gunasekera A et al (2016) Safety, immunogenicity, and protective efficacy of intradermal immunization with aseptic, purified, cryopreserved Plasmodium falciparum sporozoites in volunteers under chloroquine prophylaxis: a randomized controlled trial. Am J Trop Med Hyg 94:663\u2013673","journal-title":"Am J Trop Med Hyg"},{"key":"301_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-4894(77)90054-6","volume":"42","author":"RL Beaudoin","year":"1977","unstructured":"Beaudoin RL, Strome CP, Mitchell F, Tubergen TA (1977) Plasmodium berghei: immunization of mice against the ANKA strain using the unaltered sporozoite as an antigen. Exp Parasitol 42:1\u20135","journal-title":"Exp Parasitol"},{"key":"301_CR3","doi-asserted-by":"crossref","first-page":"564","DOI":"10.4269\/ajtmh.1991.44.564","volume":"44","author":"JC Beier","year":"1991","unstructured":"Beier JC, Davis JR, Vaughan JA, Noden BH, Beier MS (1991) Quantitation of Plasmodium falciparum sporozoites transmitted in vitro by experimentally infected Anopheles gambiae and Anopheles stephensi. Am J Trop Med Hyg 44:564\u2013570","journal-title":"Am J Trop Med Hyg"},{"key":"301_CR4","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.4049\/jimmunol.172.4.2487","volume":"172","author":"E Belnoue","year":"2004","unstructured":"Belnoue E, Costa FT, Frankenberg T, Vigario AM, Voza T, Leroy N, Rodrigues MM, Landau I, Snounou G, Renia L (2004) Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment. J Immunol 172:2487\u20132495","journal-title":"J Immunol"},{"key":"301_CR5","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.4049\/jimmunol.171.4.2024","volume":"171","author":"D Berenzon","year":"2003","unstructured":"Berenzon D, Schwenk RJ, Letellier L, Guebre-Xabier M, Williams J, Krzych U (2003) Protracted protection to Plasmodium berghei malaria is linked to functionally and phenotypically heterogeneous liver memory CD8+ T cells. J Immunol 171:2024\u20132034","journal-title":"J Immunol"},{"key":"301_CR6","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nm.4381","volume":"23","author":"B Blasco","year":"2017","unstructured":"Blasco B, Leroy D, Fidock DA (2017) Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic. Nat Med 23:917\u2013928","journal-title":"Nat Med"},{"key":"301_CR7","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.coi.2011.05.009","volume":"23","author":"S Borrmann","year":"2011","unstructured":"Borrmann S, Matuschewski K (2011a) Protective immunity against malaria by \u2018natural immunization\u2019: a question of dose, parasite diversity, or both? Curr Opin Immunol 23:500\u2013508","journal-title":"Curr Opin Immunol"},{"key":"301_CR8","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.molmed.2011.05.008","volume":"17","author":"S Borrmann","year":"2011","unstructured":"Borrmann S, Matuschewski K (2011b) Targeting Plasmodium liver stages: better late than never. Trends Mol Med 17:527\u2013536","journal-title":"Trends Mol Med"},{"key":"301_CR9","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.chom.2011.05.008","volume":"9","author":"NS Butler","year":"2011","unstructured":"Butler NS, Schmidt NW, Vaughan AM, Aly AS, Kappe SH, Harty JT (2011) Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasites. Cell Host Microbe 9:451\u2013462","journal-title":"Cell Host Microbe"},{"key":"301_CR10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1006\/expr.1995.1049","volume":"80","author":"CJ Canfield","year":"1995","unstructured":"Canfield CJ, Pudney M, Gutteridge WE (1995) Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro. Exp Parasitol 80:373\u2013381","journal-title":"Exp Parasitol"},{"key":"301_CR11","volume":"9","author":"D Chen","year":"2018","unstructured":"Chen D, Xie J, Fiskesund R, Dong W, Liang X, Lv J, Jin X, Liu J, Mo S, Zhang T et al (2018) Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotype. Nat Commun 9:873","journal-title":"Nat Commun"},{"key":"301_CR12","doi-asserted-by":"crossref","first-page":"e1001318","DOI":"10.1371\/journal.ppat.1001318","volume":"7","author":"IA Cockburn","year":"2011","unstructured":"Cockburn IA, Tse SW, Radtke AJ, Srinivasan P, Chen YC, Sinnis P, Zavala F (2011) Dendritic cells and hepatocytes use distinct pathways to process protective antigen from Plasmodium in vivo. PLoS Pathog 7:e1001318","journal-title":"PLoS Pathog"},{"key":"301_CR13","first-page":"115","volume":"58","author":"CS Davies","year":"1989","unstructured":"Davies CS, Pudney M, Matthews PJ, Sinden RE (1989) The causal prophylactic activity of the novel hydroxynaphthoquinone 566C80 against Plasmodium berghei infections in rats. Acta Leiden 58:115\u2013128","journal-title":"Acta Leiden"},{"key":"301_CR14","unstructured":"Deutsche Gesellschaft f\u00fcr Tropenmedizin und Internationale Gesundheit (DTG) (2016) Leitlinie: diagnostik und therapie der malaria. DTG, Hamburg."},{"key":"301_CR15","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/cid\/cir770","volume":"54","author":"GA Deye","year":"2012","unstructured":"Deye GA, Miller RS, Miller L, Salas CJ, Tosh D, Macareo L, Smith BL, Fracisco S, Clemens EG, Murphy J et al (2012) Prolonged protection provided by a single dose of atovaquone-proguanil for the chemoprophylaxis of Plasmodium falciparum malaria in a human challenge model. Clin Infect Dis 54:232\u2013239","journal-title":"Clin Infect Dis"},{"key":"301_CR16","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.4049\/jimmunol.165.3.1453","volume":"165","author":"DL Doolan","year":"2000","unstructured":"Doolan DL, Hoffman SL (2000) The complexity of protective immunity against liver-stage malaria. J Immunol 165:1453\u20131462","journal-title":"J Immunol"},{"key":"301_CR17","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1002\/pmic.200800194","volume":"8","author":"DL Doolan","year":"2008","unstructured":"Doolan DL, Mu Y, Unal B, Sundaresh S, Hirst S, Valdez C, Randall A, Molina D, Liang X, Freilich DA et al (2008) Profiling humoral immune responses to P. falciparum infection with protein microarrays. Proteomics 8:4680\u20134694","journal-title":"Proteomics"},{"key":"301_CR18","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89154","volume":"2","author":"JE Epstein","year":"2017","unstructured":"Epstein JE, Paolino KM, Richie TL, Sedegah M, Singer A, Ruben AJ, Chakravarty S, Stafford A, Ruck RC, Eappen AG et al (2017) Protection against Plasmodium falciparum malaria by PfSPZ Vaccine. JCI Insight 2:e89154","journal-title":"JCI Insight"},{"key":"301_CR19","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1126\/science.1211548","volume":"334","author":"JE Epstein","year":"2011","unstructured":"Epstein JE, Tewari K, Lyke KE, Sim BK, Billingsley PF, Laurens MB, Gunasekera A, Chakravarty S, James ER, Sedegah M et al (2011) Live attenuated malaria vaccine designed to protect through hepatic CD8(+) T cell immunity. Science 334:475\u2013480","journal-title":"Science"},{"key":"301_CR84","doi-asserted-by":"crossref","unstructured":"Feldmann AM, Ponnudurai T (1989) Selection of Anopheles stephensi for refractoriness and susceptibility to Plasmodium falciparum. Med Vet Entomol 3:41\u201352","DOI":"10.1111\/j.1365-2915.1989.tb00473.x"},{"key":"301_CR20","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.immuni.2016.08.011","volume":"45","author":"D Fernandez-Ruiz","year":"2016","unstructured":"Fernandez-Ruiz D, Ng WY, Holz LE, Ma JZ, Zaid A, Wong YC, Lau LS, Mollard V, Cozijnsen A, Collins N et al (2016) Liver-resident memory CD8+ T cells form a front-line defense against malaria liver-stage infection. Immunity 45:889\u2013902","journal-title":"Immunity"},{"key":"301_CR21","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1124\/mol.54.6.1140","volume":"54","author":"DA Fidock","year":"1998","unstructured":"Fidock DA, Nomura T, Wellems TE (1998) Cycloguanil and its parent compound proguanil demonstrate distinct activities against Plasmodium falciparum malaria parasites transformed with human dihydrofolate reductase. Mol Pharmacol 54:1140\u20131147","journal-title":"Mol Pharmacol"},{"key":"301_CR22","doi-asserted-by":"crossref","first-page":"452","DOI":"10.2307\/3283831","volume":"81","author":"RE Fowler","year":"1995","unstructured":"Fowler RE, Sinden RE, Pudney M (1995) Inhibitory activity of the anti-malarial atovaquone (566C80) against ookinetes, oocysts, and sporozoites of Plasmodium berghei. J Parasitol 81:452\u2013458","journal-title":"J Parasitol"},{"key":"301_CR23","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1128\/AAC.01717-10","volume":"55","author":"J Friesen","year":"2011","unstructured":"Friesen J, Borrmann S, Matuschewski K (2011) Induction of antimalaria immunity by pyrimethamine prophylaxis during exposure to sporozoites is curtailed by parasite resistance. Antimicrob Agents Chemother 55:2760\u20132767","journal-title":"Antimicrob Agents Chemother"},{"key":"301_CR24","doi-asserted-by":"crossref","first-page":"7002","DOI":"10.1016\/j.vaccine.2011.07.034","volume":"29","author":"J Friesen","year":"2011","unstructured":"Friesen J, Matuschewski K (2011) Comparative efficacy of pre-erythrocytic whole organism vaccine strategies against the malaria parasite. Vaccine 29:7002\u20137008","journal-title":"Vaccine"},{"key":"301_CR25","doi-asserted-by":"crossref","first-page":"40ra49","DOI":"10.1126\/scitranslmed.3001058","volume":"2","author":"J Friesen","year":"2010","unstructured":"Friesen J, Silvie O, Putrianti ED, Hafalla JC, Matuschewski K, Borrmann S (2010) Natural immunization against malaria: causal prophylaxis with antibiotics. Sci Transl Med 2:40ra49","journal-title":"Sci Transl Med"},{"key":"301_CR26","volume":"14","author":"GP Gomez-Perez","year":"2015","unstructured":"Gomez-Perez GP, Legarda A, Munoz J, Sim BK, Ballester MR, Dobano C, Moncunill G, Campo JJ, Cistero P, Jimenez A et al (2015) Controlled human malaria infection by intramuscular and direct venous inoculation of cryopreserved Plasmodium falciparum sporozoites in malaria-naive volunteers: effect of injection volume and dose on infectivity rates. Malar J 14:306","journal-title":"Malar J"},{"key":"301_CR27","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s44321-024-00057-7","volume":"16","author":"D Goswami","year":"2024","unstructured":"Goswami D, Patel H, Betz W, Armstrong J, Camargo N, Patil A, Chakravarty S, Murphy SC, Sim BKL, Vaughan AM et al (2024) A replication competent Plasmodium falciparum parasite completely attenuated by dual gene deletion. EMBO Mol Med 16:723\u2013754","journal-title":"EMBO Mol Med"},{"key":"301_CR28","doi-asserted-by":"crossref","first-page":"e1003303","DOI":"10.1371\/journal.ppat.1003303","volume":"9","author":"JC Hafalla","year":"2013","unstructured":"Hafalla JC, Bauza K, Friesen J, Gonzalez-Aseguinolaza G, Hill AV, Matuschewski K (2013) Identification of targets of CD8(+) T cell responses to malaria liver stages by genome-wide epitope profiling. PLoS Pathog 9:e1003303","journal-title":"PLoS Pathog"},{"key":"301_CR29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.pt.2024.12.015","volume":"41","author":"JCR Hafalla","year":"2025","unstructured":"Hafalla JCR, Borrmann S, Matuschewski K (2025) Genetically attenuated parasites show promise as a next-generation malaria vaccine. Trends Parasitol 41:75\u201377","journal-title":"Trends Parasitol"},{"key":"301_CR30","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4161\/hv.6.1.10396","volume":"6","author":"SL Hoffman","year":"2010","unstructured":"Hoffman SL, Billingsley PF, James E, Richman A, Loyevsky M, Li T, Chakravarty S, Gunasekera A, Chattopadhyay R, Li M et al (2010) Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria. Hum Vaccin 6:97\u2013106","journal-title":"Hum Vaccin"},{"key":"301_CR31","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1086\/339409","volume":"185","author":"SL Hoffman","year":"2002","unstructured":"Hoffman SL, Goh LM, Luke TC, Schneider I, Le TP, Doolan DL, Sacci J, de la Vega P, Dowler M, Paul C et al (2002) Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis 185:1155\u20131164","journal-title":"J Infect Dis"},{"key":"301_CR32","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/nm.4110","volume":"22","author":"AS Ishizuka","year":"2016","unstructured":"Ishizuka AS, Lyke KE, DeZure A, Berry AA, Richie TL, Mendoza FH, Enama ME, Gordon IJ, Chang LJ, Sarwar UN et al (2016) Protection against malaria at 1 year and immune correlates following PfSPZ vaccination. Nat Med 22:614\u2013623","journal-title":"Nat Med"},{"key":"301_CR33","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/nprot.2006.88","volume":"1","author":"CJ Janse","year":"2006","unstructured":"Janse CJ, Franke-Fayard B, Waters AP (2006) Selection by flow-sorting of genetically transformed, GFP-expressing blood stages of the rodent malaria parasite, Plasmodium berghei. Nat Protoc 1:614\u2013623","journal-title":"Nat Protoc"},{"key":"301_CR34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0035-9203(88)90262-3","volume":"82","author":"JB Jiang","year":"1988","unstructured":"Jiang JB, Bray RS, Krotoski WA, Canning EU, Liang DS, Huang JC, Liao JY, Li DS, Lun ZR, Landau I et al (1988) Observations on early and late post-sporozoite tissue stages in primate malaria. V. The effect of pyrimethamine and proguanil upon tissue hypnozoites and schizonts of Plasmodium cynomolgi bastianellii. Trans R Soc Trop Med Hyg 82:56\u201358","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"301_CR35","doi-asserted-by":"crossref","first-page":"e00061-19","DOI":"10.1128\/mSphereDirect.00061-19","volume":"4","author":"T Kobayashi","year":"2019","unstructured":"Kobayashi T, Jain A, Liang L, Obiero JM, Hamapumbu H, Stevenson JC, Thuma PE, Lupiya J, Chaponda M, Mulenga M et al (2019) Distinct antibody signatures associated with different malaria transmission intensities in Zambia and Zimbabwe. mSphere 4:e00061-19","journal-title":"mSphere"},{"key":"301_CR36","doi-asserted-by":"crossref","first-page":"565.e6","DOI":"10.1016\/j.chom.2019.02.014","volume":"25","author":"SP Kurup","year":"2019","unstructured":"Kurup SP, Anthony SM, Hancox LS, Vijay R, Pewe LL, Moioffer SJ, Sompallae R, Janse CJ, Khan SM, Harty JT (2019) Monocyte-derived CD11c(+) cells acquire Plasmodium from hepatocytes to prime CD8 T cell immunity to liver-stage malaria. Cell Host Microbe 25:565.e6\u2013577.e6","journal-title":"Cell Host Microbe"},{"key":"301_CR37","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1056\/NEJMoa2313892","volume":"391","author":"OAC Lamers","year":"2024","unstructured":"Lamers OAC, Franke-Fayard BMD, Koopman JPR, Roozen GVT, Janse JJ, Chevalley-Maurel SC, Geurten FJA, de Bes-Roeleveld HM, Iliopoulou E, Colstrup E et al (2024) Safety and efficacy of immunization with a late-liver-stage attenuated malaria parasite. N Engl J Med 391:1913\u20131923","journal-title":"N Engl J Med"},{"key":"301_CR38","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1073\/pnas.1615324114","volume":"114","author":"KE Lyke","year":"2017","unstructured":"Lyke KE, Ishizuka AS, Berry AA, Chakravarty S, DeZure A, Enama ME, James ER, Billingsley PF, Gunasekera A, Manoj A et al (2017) Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection. Proc Natl Acad Sci USA 114:2711\u20132716","journal-title":"Proc Natl Acad Sci USA"},{"key":"301_CR39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000398","volume":"8","author":"malERA Consultative Group on Vaccines","year":"2011","unstructured":"malERA Consultative Group on Vaccines (2011) A research agenda for malaria eradication: vaccines. PLoS Med 8:e1000398","journal-title":"PLoS Med"},{"key":"301_CR40","doi-asserted-by":"crossref","first-page":"Article24","DOI":"10.2202\/1544-6115.1237","volume":"5","author":"M McGee","year":"2006","unstructured":"McGee M, Chen Z (2006) Parameter estimation for the exponential-normal convolution model for background correction of affymetrix GeneChip data. Stat Appl Genet Mol Biol 5:Article24","journal-title":"Stat Appl Genet Mol Biol"},{"key":"301_CR41","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.virol.2015.03.032","volume":"479-480","author":"PD Minor","year":"2015","unstructured":"Minor PD (2015) Live attenuated vaccines: historical successes and current challenges. Virology 479-480:379\u2013392","journal-title":"Virology"},{"key":"301_CR42","doi-asserted-by":"crossref","first-page":"e01321-14","DOI":"10.1128\/mBio.01321-14","volume":"5","author":"GN Montagna","year":"2014","unstructured":"Montagna GN, Beigier-Bompadre M, Becker M, Kroczek RA, Kaufmann SH, Matuschewski K (2014) Antigen export during liver infection of the malaria parasite augments protective immunity. mBio 5:e01321-14","journal-title":"mBio"},{"key":"301_CR43","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0140-6736(23)02743-5","volume":"403","author":"V Moorthy","year":"2024","unstructured":"Moorthy V, Hamel MJ, Smith PG (2024) Malaria vaccines for children: and now there are two. Lancet 403:504\u2013505","journal-title":"Lancet"},{"key":"301_CR44","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/S0140-6736(13)62238-2","volume":"382","author":"VS Moorthy","year":"2013","unstructured":"Moorthy VS, Newman RD, Okwo-Bele JM (2013) Malaria vaccine technology roadmap. Lancet 382:1700\u20131701","journal-title":"Lancet"},{"key":"301_CR45","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-022-00510-z","volume":"7","author":"B Mordmuller","year":"2022","unstructured":"Mordmuller B, Sulyok Z, Sulyok M, Molnar Z, Lalremruata A, Calle CL, Bayon PG, Esen M, Gmeiner M, Held J et al (2022) A PfSPZ vaccine immunization regimen equally protective against homologous and heterologous controlled human malaria infection. npj Vaccines 7:100","journal-title":"npj Vaccines"},{"key":"301_CR46","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-015-0628-0","volume":"14","author":"B Mordm\u00fcller","year":"2015","unstructured":"Mordm\u00fcller B, Supan C, Sim KL, Gomez-Perez GP, Ospina Salazar CL, Held J, Bolte S, Esen M, Tschan S, Joanny F et al (2015) Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres. Malar J 14:117","journal-title":"Malar J"},{"key":"301_CR47","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature21060","volume":"542","author":"B Mordm\u00fcller","year":"2017","unstructured":"Mordm\u00fcller B, Surat G, Lagler H, Chakravarty S, Ishizuka AS, Lalremruata A, Gmeiner M, Campo JJ, Esen M, Ruben AJ et al (2017) Sterile protection against human malaria by chemoattenuated PfSPZ vaccine. Nature 542:445\u2013449","journal-title":"Nature"},{"key":"301_CR48","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1073\/pnas.0408442102","volume":"102","author":"AK Mueller","year":"2005","unstructured":"Mueller AK, Camargo N, Kaiser K, Andorfer C, Frevert U, Matuschewski K, Kappe SH (2005a) Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface. Proc Natl Acad Sci USA 102:3022\u20133027","journal-title":"Proc Natl Acad Sci USA"},{"key":"301_CR49","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nature03188","volume":"433","author":"AK Mueller","year":"2005","unstructured":"Mueller AK, Labaied M, Kappe SH, Matuschewski K (2005b) Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Nature 433:164\u2013167","journal-title":"Nature"},{"key":"301_CR85","doi-asserted-by":"crossref","unstructured":"M\u00fcller K, Matuschewski K, Silvie O (2011) The Puf-family RNA-binding protein Puf2 controls sporozoite conversion to liver stages in the malaria parasite. PLoS ONE 6:e19860","DOI":"10.1371\/journal.pone.0019860"},{"key":"301_CR50","doi-asserted-by":"crossref","DOI":"10.1111\/pim.12434","volume":"39","author":"K M\u00fcller","year":"2017","unstructured":"M\u00fcller K, Gibbins MP, Matuschewski K, Hafalla JCR (2017) Evidence of cross-stage CD8+ T cell epitopes in malaria pre-erythrocytic and blood stage infections. Parasite Immunol 39:e12434","journal-title":"Parasite Immunol"},{"key":"301_CR51","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-021-03684-z","volume":"595","author":"A Mwakingwe-Omari","year":"2021","unstructured":"Mwakingwe-Omari A, Healy SA, Lane J, Cook DM, Kalhori S, Wyatt C, Kolluri A, Marte-Salcedo O, Imeru A, Nason M et al (2021) Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunity. Nature 595:289\u2013294","journal-title":"Nature"},{"key":"301_CR52","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S0264-410X(97)00238-7","volume":"16","author":"EH Nardin","year":"1998","unstructured":"Nardin EH, Calvo-Calle JM, Oliveira GA, Clavijo P, Nussenzweig R, Simon R, Zeng W, Rose K (1998) Plasmodium falciparum polyoximes: highly immunogenic synthetic vaccines constructed by chemoselective ligation of repeat B-cell epitopes and a universal T-cell epitope of CS protein. Vaccine 16:590\u2013600","journal-title":"Vaccine"},{"key":"301_CR86","unstructured":"Nakabayashi H, Taketa K, Miyano K, Yamane T, Sato J (1982) Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res 42:3858\u20133863"},{"key":"301_CR53","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMoa1505819","volume":"373","author":"DE Neafsey","year":"2015","unstructured":"Neafsey DE, Juraska M, Bedford T, Benkeser D, Valim C, Griggs A, Lievens M, Abdulla S, Adjei S, Agbenyega T et al (2015) Genetic diversity and protective efficacy of the RTS,S\/AS01 malaria vaccine. N Engl J Med 373:2025\u20132037","journal-title":"N Engl J Med"},{"key":"301_CR54","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/216160a0","volume":"216","author":"RS Nussenzweig","year":"1967","unstructured":"Nussenzweig RS, Vanderberg J, Most H, Orton C (1967) Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. Nature 216:160\u2013162","journal-title":"Nature"},{"key":"301_CR55","doi-asserted-by":"crossref","first-page":"e00027-19","DOI":"10.1128\/mSphereDirect.00027-19","volume":"4","author":"JM Obiero","year":"2019","unstructured":"Obiero JM, Campo JJ, Scholzen A, Randall A, Bijker EM, Roestenberg M, Hermsen CC, Teng A, Jain A, Davies DH et al (2019) Antibody biomarkers associated with sterile protection induced by controlled human malaria infection under chloroquine prophylaxis. mSphere 4:e00027-19","journal-title":"mSphere"},{"key":"301_CR56","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ijpara.2012.03.011","volume":"42","author":"V Offeddu","year":"2012","unstructured":"Offeddu V, Thathy V, Marsh K, Matuschewski K (2012) Naturally acquired immune responses against Plasmodium falciparum sporozoites and liver infection. Int J Parasitol 42:535\u2013548","journal-title":"Int J Parasitol"},{"key":"301_CR57","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41586-019-0973-1","volume":"567","author":"DG Paton","year":"2019","unstructured":"Paton DG, Childs LM, Itoe MA, Holmdahl IE, Buckee CO, Catteruccia F (2019) Exposing Anopheles mosquitoes to antimalarials blocks Plasmodium parasite transmission. Nature 567:239\u2013243","journal-title":"Nature"},{"key":"301_CR58","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.798859","volume":"12","author":"YT Pinilla","year":"2021","unstructured":"Pinilla YT, Heinzel C, Caminada LF, Consolaro D, Esen M, Kremsner PG, Held J, Kreidenweiss A, Fendel R (2021) SARS-CoV-2 antibodies are persisting in saliva for more than 15 months after infection and become strongly boosted after vaccination. Front Immunol 12:798859","journal-title":"Front Immunol"},{"key":"301_CR59","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1086\/589862","volume":"47","author":"SA Plotkin","year":"2008","unstructured":"Plotkin SA (2008) Vaccines: correlates of vaccine-induced immunity. Clin Infect Dis 47:401\u2013409","journal-title":"Clin Infect Dis"},{"key":"301_CR60","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1086\/597121","volume":"199","author":"ED Putrianti","year":"2009","unstructured":"Putrianti ED, Silvie O, Kordes M, Borrmann S, Matuschewski K (2009) Vaccine-like immunity against malaria by repeated causal-prophylactic treatment of liver-stage Plasmodium parasites. J Infect Dis 199:899\u2013903","journal-title":"J Infect Dis"},{"key":"301_CR61","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0140-6736(96)90671-6","volume":"347","author":"PD Radloff","year":"1996","unstructured":"Radloff PD, Philipps J, Nkeyi M, Hutchinson D, Kremsner PG (1996) Atovaquone and proguanil for Plasmodium falciparum malaria. Lancet 347:1511\u20131514","journal-title":"Lancet"},{"key":"301_CR62","doi-asserted-by":"crossref","first-page":"7452","DOI":"10.1016\/j.vaccine.2015.09.096","volume":"33","author":"TL Richie","year":"2015","unstructured":"Richie TL, Billingsley PF, Sim BK, James ER, Chakravarty S, Epstein JE, Lyke KE, Mordmuller B, Alonso P, Duffy PE et al (2015) Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines. Vaccine 33:7452\u20137461","journal-title":"Vaccine"},{"key":"301_CR63","first-page":"1","volume":"80","author":"M Rodrigues","year":"1993","unstructured":"Rodrigues M, Nussenzweig RS, Zavala F (1993) The relative contribution of antibodies, CD4+ and CD8+ T cells to sporozoite-induced protection against malaria. Immunology 80:1\u20135","journal-title":"Immunology"},{"key":"301_CR64","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4269\/ajtmh.2012.12-0613","volume":"88","author":"M Roestenberg","year":"2013","unstructured":"Roestenberg M, Bijker EM, Sim BK, Billingsley PF, James ER, Bastiaens GJ, Teirlinck AC, Scholzen A, Teelen K, Arens T et al (2013) Controlled human malaria infections by intradermal injection of cryopreserved Plasmodium falciparum sporozoites. Am J Trop Med Hyg 88:5\u201313","journal-title":"Am J Trop Med Hyg"},{"key":"301_CR65","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1056\/NEJMoa0805832","volume":"361","author":"M Roestenberg","year":"2009","unstructured":"Roestenberg M, McCall M, Hopman J, Wiersma J, Luty AJ, van Gemert GJ, van de Vegte-Bolmer M, van Schaijk B, Teelen K, Arens T et al (2009) Protection against a malaria challenge by sporozoite inoculation. N Engl J Med 361:468\u2013477","journal-title":"N Engl J Med"},{"key":"301_CR66","doi-asserted-by":"crossref","first-page":"eaaz5629","DOI":"10.1126\/scitranslmed.aaz5629","volume":"12","author":"M Roestenberg","year":"2020","unstructured":"Roestenberg M, Walk J, van der Boor SC, Langenberg MCC, Hoogerwerf MA, Janse JJ, Manurung M, Yap XZ, Garcia AF, Koopman JPR et al (2020) A double-blind, placebo-controlled phase 1\/2a trial of the genetically attenuated malaria vaccine PfSPZ-GA1. Sci Transl Med 12:eaaz5629","journal-title":"Sci Transl Med"},{"issue":"1","key":"301_CR67","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41591-024-03347-2","volume":"31","author":"GVT Roozen","year":"2025","unstructured":"Roozen GVT, van Schuijlenburg R, Hensen ADO, Koopman JPR, Lamers OAC, Geurten FJA, Sijtsma JC, Baalbergen E, Janse JJ, Chevalley-Maurel S et al (2025) Single immunization with genetically attenuated Pf\u2206mei2 (GA2) parasites by mosquito bite in controlled human malaria infection: a placebo-controlled randomized trial. Nat Med 31(1):218\u2013222","journal-title":"Nat Med"},{"key":"301_CR68","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1073\/pnas.92.9.4066","volume":"92","author":"LF Scheller","year":"1995","unstructured":"Scheller LF, Azad AF (1995) Maintenance of protective immunity against malaria by persistent hepatic parasites derived from irradiated sporozoites. Proc Natl Acad Sci USA 92:4066\u20134068","journal-title":"Proc Natl Acad Sci USA"},{"key":"301_CR69","doi-asserted-by":"crossref","first-page":"14017","DOI":"10.1073\/pnas.0805452105","volume":"105","author":"NW Schmidt","year":"2008","unstructured":"Schmidt NW, Podyminogin RL, Butler NS, Badovinac VP, Tucker BJ, Bahjat KS, Lauer P, Reyes-Sandoval A, Hutchings CL, Moore AC et al (2008) Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria. Proc Natl Acad Sci USA 105:14017\u201314022","journal-title":"Proc Natl Acad Sci USA"},{"key":"301_CR70","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/330664a0","volume":"330","author":"L Schofield","year":"1987","unstructured":"Schofield L, Villaquiran J, Ferreira A, Schellekens H, Nussenzweig R, Nussenzweig V (1987) Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature 330:664\u2013666","journal-title":"Nature"},{"key":"301_CR71","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1126\/science.1241800","volume":"341","author":"RA Seder","year":"2013","unstructured":"Seder RA, Chang LJ, Enama ME, Zephir KL, Sarwar UN, Gordon IJ, Holman LA, James ER, Billingsley PF, Gunasekera A et al (2013) Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science 341:1359\u20131365","journal-title":"Science"},{"key":"301_CR72","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/biostatistics\/kxn042","volume":"10","author":"JD Silver","year":"2009","unstructured":"Silver JD, Ritchie ME, Smyth GK (2009) Microarray background correction: maximum likelihood estimation for the normal-exponential convolution. Biostatistics 10:352\u2013363","journal-title":"Biostatistics"},{"key":"301_CR73","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.cell.2007.09.013","volume":"131","author":"AP Singh","year":"2007","unstructured":"Singh AP, Buscaglia CA, Wang Q, Levay A, Nussenzweig DR, Walker JR, Winzeler EA, Fujii H, Fontoura BM, Nussenzweig V (2007) Plasmodium circumsporozoite protein promotes the development of the liver stages of the parasite. Cell 131:492\u2013504","journal-title":"Cell"},{"key":"301_CR74","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S1473-3099(17)30104-4","volume":"17","author":"MS Sissoko","year":"2017","unstructured":"Sissoko MS, Healy SA, Katile A, Omaswa F, Zaidi I, Gabriel EE, Kamate B, Samake Y, Guindo MA, Dolo A et al (2017) Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial. Lancet Infect Dis 17:498\u2013509","journal-title":"Lancet Infect Dis"},{"key":"301_CR75","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1473-3099(21)00332-7","volume":"22","author":"MS Sissoko","year":"2022","unstructured":"Sissoko MS, Healy SA, Katile A, Zaidi I, Hu Z, Kamate B, Samake Y, Sissoko K, Mwakingwe-Omari A, Lane J et al (2022) Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial. Lancet Infect Dis 22:377\u2013389","journal-title":"Lancet Infect Dis"},{"key":"301_CR76","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-22740-w","volume":"12","author":"Z Sulyok","year":"2021","unstructured":"Sulyok Z, Fendel R, Eder B, Lorenz FR, Kc N, Karnahl M, Lalremruata A, Nguyen TT, Held J, Adjadi FAC et al (2021) Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial. Nat Commun 12:2518","journal-title":"Nat Commun"},{"key":"301_CR77","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/BF00932618","volume":"80","author":"M Tsuji","year":"1994","unstructured":"Tsuji M, Mattei D, Nussenzweig RS, Eichinger D, Zavala F (1994) Demonstration of heat-shock protein 70 in the sporozoite stage of malaria parasites. Parasitol Res 80:16\u201321","journal-title":"Parasitol Res"},{"key":"301_CR78","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105364","volume":"108","author":"A Tumbo","year":"2024","unstructured":"Tumbo A, Lorenz FR, Yang ASP, Sefried S, Schindler T, Mpina M, Dangy JP, Milando FA, Rashid MA, Nyaulingo G et al (2024) PfSPZ Vaccine induces focused humoral immune response in HIV positive and negative Tanzanian adults. EBioMedicine 108:105364","journal-title":"EBioMedicine"},{"key":"301_CR79","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2875-13-38","volume":"13","author":"MP van Meer","year":"2014","unstructured":"van Meer MP, Bastiaens GJ, Boulaksil M, de Mast Q, Gunasekera A, Hoffman SL, Pop G, van der Ven AJ, Sauerwein RW (2014) Idiopathic acute myocarditis during treatment for controlled human malaria infection: a case report. Malar J 13:38","journal-title":"Malar J"},{"key":"301_CR80","doi-asserted-by":"crossref","first-page":"a025486","DOI":"10.1101\/cshperspect.a025486","volume":"7","author":"AM Vaughan","year":"2017","unstructured":"Vaughan AM, Kappe SHI (2017) Malaria parasite liver infection and exoerythrocytic biology. Cold Spring Harb Perspect Med 7:a025486","journal-title":"Cold Spring Harb Perspect Med"},{"key":"301_CR81","doi-asserted-by":"crossref","first-page":"e31247","DOI":"10.1371\/journal.pone.0031247","volume":"7","author":"WR Weiss","year":"2012","unstructured":"Weiss WR, Jiang CG (2012) Protective CD8+ T lymphocytes in primates immunized with malaria sporozoites. PLoS ONE 7:e31247","journal-title":"PLoS ONE"},{"key":"301_CR82","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1073\/pnas.85.2.573","volume":"85","author":"WR Weiss","year":"1988","unstructured":"Weiss WR, Sedegah M, Beaudoin RL, Miller LH, Good MF (1988) CD8+ T cells (cytotoxic\/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc Natl Acad Sci USA 85:573\u2013576","journal-title":"Proc Natl Acad Sci USA"},{"key":"301_CR83","unstructured":"WHO (2024) Malaria report 2024. World Health Organisation, Geneva."}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-025-00301-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-025-00301-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-025-00301-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T13:34:22Z","timestamp":1786973662000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-025-00301-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":86,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11,10]]}},"alternative-id":["301"],"URL":"https:\/\/doi.org\/10.1038\/s44321-025-00301-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.09.14.296152","asserted-by":"object"}]},"ISSN":["1757-4676","1757-4684"],"issn-type":[{"value":"1757-4676","type":"print"},{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"14 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"ERJ, YA, SC, NKC, TM, BKLS, TLR and SLH are all full-time employees of Sanaria Inc., Rockville, MD, the developer and owner of PfSPZ products. PFB, AR and AM were full-time employees of Sanaria Inc. at the time the work was performed. BKLS and SLH have financial interests in Sanaria Inc. and are named inventors of patents related to Purified\n                      Plasmodium\n                      and Vaccine compositions.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}],"article-number":"4"}}